{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:21:10Z","timestamp":1764174070684,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:00:00Z","timestamp":1441756800000},"content-version":"vor","delay-in-days":404,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P01 306 CA15396"],"award-info":[{"award-number":["P01 306 CA15396"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.bbmt.2014.03.033","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T05:48:31Z","timestamp":1397368111000},"page":"1130-1138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Isolated Clonal Cytogenetic Abnormalities after High-Dose Therapy"],"prefix":"10.1016","volume":"20","author":[{"given":"Margaret M.","family":"Showel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Ling","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katlyn M.","family":"Briel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance A.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.03.033_bib1","first-page":"403","article-title":"Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation","volume":"85","author":"Del Ca\u00f1izo","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2014.03.033_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0145-2126(98)00139-8","article-title":"Cytogenetic and myelodysplastic alterations after autologous hemopoietic stem cell transplantation","volume":"23","author":"Lambertenghi Deliliers","year":"1999","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2014.03.033_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbmt.2008.10.009","article-title":"Late Effects after autologous hematopoietic cell transplantation","volume":"15","author":"Burns","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.033_bib4","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V95.11.3273","article-title":"Therapy-related acute myeloid leukemia and myelodysplasia after high- dose chemotherapy and autologous stem cell transplantation","volume":"95","author":"Pedersen-Bjergaard","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.03.033_bib5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.2010.28.9777","article-title":"Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma","volume":"29","author":"Tarella","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/annonc\/mdf109","article-title":"Risk of therapy-related myelodysplastic syndrome\/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma","volume":"13","author":"Hosing","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib7","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2001.19.9.2472","article-title":"Detection of chromosome abnormalities pre\u2013high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's Lymphoma","volume":"19","author":"Lillington","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib8","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood-2002-04-1261","article-title":"Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study","volume":"101","author":"Metayer","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.03.033_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1182\/blood-2007-06-097444","article-title":"Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3000 patients treated since 1989","volume":"111","author":"Barlogie","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.03.033_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s004320050156","article-title":"Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies","volume":"124","author":"Kollmannsberger","year":"1998","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bbmt.2007.01.079","article-title":"Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation","volume":"13","author":"Armand","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.033_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.seminoncol.2008.04.012","article-title":"Therapy-related myeloid leukemia","volume":"35","author":"Godley","year":"2008","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.bmt.1705547","article-title":"Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?","volume":"39","author":"Hake","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.033_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.bmt.1701105","article-title":"New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis","volume":"21","author":"Imrie","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.033_bib15","first-page":"59","article-title":"Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies","volume":"87","author":"Laurenti","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2014.03.033_bib16","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/sj.bmt.1702416","article-title":"Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome","volume":"25","author":"Mart\u00ednez-Climent","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.033_bib17","first-page":"509","article-title":"Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide","volume":"7","author":"Perot","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.03.033_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1701053","article-title":"Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients","volume":"21","author":"Soligo","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.03.033_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2141.2008.07023.x","article-title":"Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma","volume":"141","author":"Basecke","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib20","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1200\/JCO.2007.15.5507","article-title":"Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma","volume":"26","author":"Goodman","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib21","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V89.7.2578","article-title":"stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy","volume":"89","author":"Anderson","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.03.033_bib22","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1200\/JCO.2004.99.301","article-title":"Prognosis in therapy-related acute myeloid leukemia and impact of karyotype","volume":"22","author":"Kern","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib23","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1182\/blood-2009-06-225375","article-title":"High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up","volume":"115","author":"Brodsky","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.03.033_bib24","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3109\/10428194.2011.594191","article-title":"High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas","volume":"52","author":"Gladstone","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2014.03.033_bib25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/annonc\/mdp484","article-title":"Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma","volume":"21","author":"Kasamon","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"year":"2008","author":"Swerdlow","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","key":"10.1016\/j.bbmt.2014.03.033_bib27"},{"year":"2009","author":"Shaffer","series-title":"ISCN(2009): An international system for human cytogenetic nomenclature","key":"10.1016\/j.bbmt.2014.03.033_bib28"},{"key":"10.1016\/j.bbmt.2014.03.033_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2257.1999.00173.x","article-title":"Loss of the Y chromosome in bone marrow cells: results on 1907 consecutive cases of leukaemia and preleukaemia","volume":"21","author":"Herens","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.leu.2403187","article-title":"Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML","volume":"18","author":"Schoch","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2014.03.033_bib31","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1200\/JCO.1994.12.12.2535","article-title":"Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma","volume":"12","author":"Stone","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbmt.2014.03.033_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.1988.tb02382.x","article-title":"Late haematological complications in severe aplastic anaemia","volume":"69","author":"Tichelli","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.03.033_bib34","first-page":"1134","article-title":"Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia","volume":"11","author":"Appelbaum","year":"1987","journal-title":"Exp Hematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114002201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114002201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:48:01Z","timestamp":1761058081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879114002201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1083879114002201"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.03.033","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated Clonal Cytogenetic Abnormalities after High-Dose Therapy","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.06.021","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}